Response: Rheumatoid Arthritis and Cancer Risk in the Million Women Study
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Inflammation in cancer: therapeutic opportunities from new insights.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q Mol Cancer. 2025; 24(1):51.
PMID: 39994787 PMC: 11849313. DOI: 10.1186/s12943-025-02243-8.
References
1.
Edwards C, Arden N, Fisher D, Saperia J, Reading I, van Staa T
. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford). 2005; 44(11):1394-8.
DOI: 10.1093/rheumatology/kei024.
View
2.
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C
. The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies. J Rheumatol. 2020; 48(5):669-676.
DOI: 10.3899/jrheum.200367.
View
3.
Scott I, Whittle R, Bailey J, Twohig H, Hider S, Mallen C
. Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data. Lancet Reg Health Eur. 2022; 23:100519.
PMC: 9557034.
DOI: 10.1016/j.lanepe.2022.100519.
View
4.
Yang T, Floud S, Reeves G
. Rheumatoid arthritis and cancer risk in the Million Women Study. Int J Epidemiol. 2024; 53(2).
PMC: 10904146.
DOI: 10.1093/ije/dyae006.
View